Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT05425069
Eligibility Criteria:
Inclusion Criteria:
* Eligibility criteria Inclusion criteria
* surgery over 60 min
* ASA I - II
* Age: over 70 years old
Exclusion Criteria:
* \- Neurological, or systemic disease that affects the central nervous system in a secondary way
* Abnormal admission neurological physical exam
* Consumption of benzodiazepines, tricyclic antidepressants, sympathomimetics, modafinil, opioid analgesics, histaminergic, antihistamines, cholinergic, anticholinergics, dopaminergic, antidopaminergic, and antihypertensive with alpha-agonist effect in the last 48 hours.
* History of adverse or allergic reactions to Propofol (allergy to soy or any other component of it)
* History of alcohol or drug abuse
* Subjects with "fast sequence induction" indication
Withdrawal criteria:
* Patients presenting with any adverse event during induction (excitation, hypotension, bradycardia \<40 x min, nausea).
* Subsequent refusal to participate in the study
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
70 Years
Study:
NCT05425069
Study Brief:
Protocol Section:
NCT05425069